+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chronic anemia increases gastric blood perfusion in non-cirrhotic and cirrhotic patients



Chronic anemia increases gastric blood perfusion in non-cirrhotic and cirrhotic patients



Gastroenterology 106(4 Suppl. ): A878




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030534997

Download citation: RISBibTeXText


Related references

Anemia increases gastric blood flow in noncirrhotic and cirrhotic patients. Gastrointestinal Endoscopy 42(5): 403-407, 1995

Focal gastric blood perfusion in relation with the endoscopic signs and liver function in cirrhotic patients. Digestion 58(1): 58-63, 1997

Focal Gastric Blood Perfusion in Relation with the Endoscopic Signs and Liver Function in Cirrhotic Patients. Digestion 58(1): 58-63, 1997

Gastric mucosal fibrosis patterns differ between cirrhotic and non-cirrhotic patients. Laboratory Investigation 68(1): 47A, 1993

Safety and efficacy of peginterferon alpha 2b plus ribavirin in pre cirrhotic and cirrhotic patients with chronic hepatitis c. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No T1221, 2003

Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver. Acta Radiologica 57(5): 572-579, 2016

Liver histology improves in both cirrhotic and non-cirrhotic patients with chronic HCV infection following consensus interferon therapy. Gastroenterology 112(4 Suppl. ): A1248, 1997

Treatment of nanb c chronic active hepatitis by alpha interferon comparison of response in cirrhotic and non cirrhotic patients. Journal of Hepatology 16(Suppl. 1): S50, 1992

Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 39(1): 66-73, 2001

Su2044 Incidence of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients With Chronic Hepatitis B (CHB): Results of a Multicenter Cohort Study. Gastroenterology 142(5): S-980-S-981, 2012

Safety and virological and histological response to combination therapy with peginterferon alpha-2b and ribavirin in pre-cirrhotic and cirrhotic patients with chronic hepatitis C. Hepatology 36(4 Part 2): 596A, 2002

Hepatic perfusion index in portal hypertension of cirrhotic and non-cirrhotic aetiologies. Nuclear Medicine Communications 17(6): 520-522, 1996

Efficacy and safety of the fixed-dose combination regimen of Mk3 [Mk-3682/grazoprevir/ruzasvir] with or without ribavirin in non-cirrhotic or cirrhotic patients with chronic Hcv Gt1, 2, 3, 4 or 6 infection (Parts A & B of C-Crest-1 & 2). Journal of Hepatology 66(1): S315-S316, 2017

Discriminant function based on hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhotic from non-cirrhotic liver diseased patients in chronic HCV infection. Clinica Chimica Acta; International Journal of Clinical Chemistry 369(1): 66-72, 2006

Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 103(6): 1875-1882, 1992